Potential Therapeutic Targets for the Treatment of HPV-Associated Malignancies

Ziyao Lu1, Shahab Haghollahi1, Muhammad Afzal1

  • 1Dartmouth Cancer Center, Manchester, NH 03104, USA.

Cancers
|October 26, 2024
PubMed

Insights

Recent advancements in treating human papillomavirus (HPV)-associated cancers involve novel therapies targeting HPV oncoproteins and leveraging the immune system. These innovative treatments offer unique opportunities for managing HPV-related malignancies.

Area of Science:

  • Oncology
  • Virology
  • Immunotherapy

Background:

  • Human papillomavirus (HPV) is a significant cause of several cancers, including cervical cancer and head and neck squamous cell carcinoma.
  • Current treatment strategies for HPV-associated cancers are evolving, with a focus on targeted therapies and immunomodulation.

Purpose of the Study:

  • To review recent therapeutic developments for HPV-associated cancers.
  • To highlight novel treatment modalities targeting key HPV oncoproteins and immune responses.

Main Methods:

  • Review of recent scientific literature on HPV-associated cancer treatments.
  • Discussion of gene-editing technologies (TALENs, CRISPR/Cas9) targeting HPV E6 and E7 oncoproteins.
  • Exploration of immunotherapies including PRR agonists, adoptive cell transfer, and tumor vaccines.

Main Results:

  • Emerging therapies show promise in targeting the specific mechanisms of HPV-driven carcinogenesis.
  • Gene editing offers a precise approach to disable viral oncogenes.
  • Immunotherapeutic strategies are advancing towards clinical trials, capitalizing on the immunogenicity of HPV-related diseases.

Conclusions:

  • HPV-associated cancers present unique therapeutic targets due to their distinct carcinogenic mechanisms.
  • Novel treatments, including gene editing and advanced immunotherapies, are poised to improve patient outcomes.
  • The reversibility and immunogenicity of HPV carcinogenesis offer distinct opportunities for innovative therapeutic interventions.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K